https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-08-01 / J Dtsch Dermatol Ges 2003 Aug;1(8):635-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-08-01 / J Dtsch Dermatol Ges 2003 Aug;1(8):635-422003-08-01 00:00:002003-08-01 00:00:00Efficacy of superficial and deep regional hyperthermia combined with systemic chemotherapy and radiotherapy in metastatic melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-02-01 / J Dtsch Dermatol Ges 2003 Feb;1(2):120-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-02-01 / J Dtsch Dermatol Ges 2003 Feb;1(2):120-52003-02-01 00:00:002019-02-15 09:19:55Intradermal injection of Newcastle disease virus-modified autologous melanoma cell lysate and interleukin-2 for adjuvant treatment of melanoma patients with resectable stage III disease
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1998-12-01 / Mol. Med. 1998 Dec;4(12):783-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1998-12-01 / Mol. Med. 1998 Dec;4(12):783-941998-12-01 00:00:001998-12-01 00:00:00A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire
